GENERAL ATLANTIC, L.P.
Q3 2025 13F Holdings
- Locationnew york, NY
- Num holdings
16
- Value ($000)
$3,330,866
- Date Filed 11/13/2025
- Form type13F-HR
- CIK 0001017645
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q3 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
DLOCAL | CLASS A COM | G29018101 | $666.26M | 20 % | 46,656,695 | ||
XP, INC | CL A | G98239109 | $479.48M | 14 % | 25,517,733 | ||
A ALIGNMENT HEALTHCARE | COM | 01625V104 | $423.81M | 13 % | 24,287,227 | ||
CHIME | COM SHS CL A | 16935C109 | $387.44M | 12 % | 19,208,760 | ||
A ALKAMI | COM | 01644J108 | $297.87M | 9 % | 11,991,480 | ||
A AKERO THERAPEUTICS | COM | 00973Y108 | $272.25M | 8 % | 5,733,989 | ||
C CENTESSA PHARMACEUTICALS | SPONSERED ADS | 152309100 | $234.78M | 7 % | 9,681,818 | ||
PHARVARIS | COM | N69605108 | $200.38M | 6 % | 8,031,252 | ||
R REVOLUTION MEDICINES | COM | 76155X100 | $115.56M | 4 % | 2,474,428 | ||
WEBULL | ORD SHS | G9572D103 | $106.47M | 3 % | 7,198,867 |
Rows Per Page
10
- 10
- 50
- 100